CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Asia Pacific Embolization Coils Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Detachable Coil and Pushable Coil), By Material (Platinum, Platinum & Hydrogel, and Platinum Tungsten Alloy), By Application (Neurology, Cardiology, Urology, Oncology, Peripheral Vascular Disease, and Others), and End User (Hospital, Cardiac Center, Ambulatory Center, and Other)
... Cardiology, Urology, Oncology, Peripheral Vascular Disease, and Others), and End User (Hospital, Cardiac Center, Ambulatory Center, and Other) The Asia Pacific embolization coils market is expected to grow from US$ 267.89 million in 2022 to ... Read More
-
Europe Embolization Coils Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Detachable Coil and Pushable Coil), By Material (Platinum, Platinum & Hydrogel, and Platinum Tungsten Alloy), By Application (Neurology, Cardiology, Urology, Oncology, Peripheral Vascular Disease, and Others), and End User (Hospital, Cardiac Center, Ambulatory Center, and Other)
... Urology, Oncology, Peripheral Vascular Disease, and Others), and End User (Hospital, Cardiac Center, Ambulatory Center, and Other) The Europe embolization coils market is expected to grow from US$ 310.02 million in 2022 to US$ 391.22 ... Read More
-
Global Cognitive Assessment and Training Solutions Market Growth (Status and Outlook) 2023-2029
... Resource, Cambridge Cognition, Cogstate Ltd, CogniFit Ltd., ERT (eResearchTechnology, Inc.), etc. Cognitive assessment and training is a formal assessment of one’s psychological functions and speed of information processing. This method of assessment helps an individual ... Read More
-
2023 Global: Alzheimer'S Disease Drug - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
Major Depressive Disorder (MDD) - Drug Pipeline Landscape, 2023
... more than 2 weeks and a loss of interest in activities thus affecting the mood and ability to function in daily life. The most common causes of Major Depressive Disorder include genetics, trauma, isolation, significant ... Read More
-
Global Glioblastoma Treatment Market - 2023-2030
... of YY% during the forecast period (2023-2030). Glioblastoma is also known as glioblastoma multiforme (GBM). Glioblastoma is an aggressive type of cancer that can occur in the brain or spinal cord. Glioblastoma forms from cells ... Read More
-
Migraine - Drug Pipeline Landscape, 2023
... last for few hours to three days. The underlying cause of migraine is unknown. It is believed that, migraine may be due to a mixture of environmental triggers and genetical factors. Change in hormonal levels ... Read More
-
2023 Global: Amyotrophic Lateral Sclerosis (Als) Treatment - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2023
... interfere with daily activities and cause significant distress. There are five types of obsessive-compulsive disorders like contamination obsessions or cleaning compulsions, harm obsessions or cleaning compulsions, obsessions without compulsions, symmetry obsessions-ordering compulsions and Hoarding. The ... Read More
-
Fibromyalgia - Drug Pipeline Landscape, 2023
... of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD. Fibromyalgia can be diagnosed if ... Read More
-
Schizophrenia - Drug Pipeline Landscape, 2023
... functioning and are disabling. The main cause of schizophrenia is not known. The condition may occur due to the interplay of physical trauma, genetic, psychological and environmental factors. Schizophrenia symptoms are classified as positive, negative, ... Read More
-
Natural Biomaterials Market, By Product Type (Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin/chitosan, Others), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Neurological Disorders/Central Nervous Systems, Tissue Engineering, Ophthalmology, and Others), and By Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Biomaterials are regarded as non-drug material, which is used for enhancing or replacing ... Read More
-
Neurology Patient Monitoring Market: Current Analysis and Forecast (2022-2028)
... is to alert the surgeon and anesthesiologist to impending injury in order to allow modification of management in time to prevent permanent damage. In some cases, neuromonitoring is used to map areas of the nervous ... Read More
-
Telemedicine Market Size By Service (Tele-consulting, Tele-monitoring, Tele-education/training), By Type (Telehospital, Telehome), By Specialty (Cardiology, Gynecology, Neurology, Orthopedics, Dermatology, Mental Health), By Delivery Mode (Web/Mobile {Telephonic, Visualized}, Call Centers), Industry Analysis Report, Regional Outlook, Type Potential, Competitive Market Share & Forecast, 2023 - 2032
... Potential, Competitive Market Share & Forecast, 2023 - 2032 Telemedicine Market is poised to grow at a steady rate between 2023 and 2032, primarily owing to the increasing prevalence of chronic diseases especially in developing ... Read More
-
Restless Legs Syndrome - Drug Pipeline Landscape, 2023
... thought to be associated with a dysfunction in the brain's dopamine system. This system is responsible for regulating movement and is also involved in the feeling of pleasure and reward. RLS is thought to be ... Read More
-
Wearable Brain Devices Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Market Is Expected to Rise as More People ... Read More
-
Traumatic Brain Injury (TBI) - Drug Pipeline Landscape, 2023
... head, the head suddenly and violently hitting an object or when an object pierces the skull and enters brain tissue. Traumatic brain injury is the leading cause of death and disability worldwide and, can be ... Read More
-
Global Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65 and 65, and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Region (North America, Europe, ... Read More
-
MEA Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Type (Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country ... Read More
-
NA Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country (U.S., Canada, ... Read More
-
APAC Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others, Country (China, Japan, South ... Read More
-
Europe Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country (Russia, Spain, Turkey, ... Read More
-
Recurrent Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Malignant Glioma - Drugs In Development, 2022, provides an overview of the Recurrent Malignant Glioma (Oncology) pipeline landscape. Recurrent malignant glioma is ... Read More
-
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) - Drugs In Development, 2022, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape. Glioblastoma also known as ... Read More
-
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningitis - Drugs In Development, 2022, provides an overview of the Meningitis (Infectious Disease) pipeline landscape. Meningitis is the inflammation caused by viruses and bacteria on the ... Read More
Research Assistance
